Telomere length and vascular wall in patients with type 2 diabetes mellitus

被引:5
|
作者
Dudinskaya, E. N. [1 ]
Tkacheva, O. N. [1 ]
Shestakova, M., V [2 ,3 ]
Brailova, N., V [1 ]
Strazhesko, I. D. [1 ]
Akasheva, D. U. [1 ]
Isaykina, O. Y. [1 ]
Pokrovskaya, M. S. [1 ]
Sharashkina, N., V [1 ]
Boytsov, S. A. [1 ]
机构
[1] Natl Res Ctr Prevent Med Moscow, Moscow, Russia
[2] Endocrinol Res Ctr, Moscow, Russia
[3] Sechenov First Moscow State Med Univ, Moscow, Russia
来源
DIABETES MELLITUS | 2014年 / 17卷 / 03期
关键词
telomere length; vascular aging; diabetes mellitus; insulin resistance;
D O I
10.14341/DM2014331-38
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study the relationship between changes in the artery structure and function and peripheral lymphocyte telomere length in patients with type 2 diabetes mellitus (DM2). Materials and methods. A total of 50 patients with T2DM and without clinical manifestations of cardiovascular disease (CVD) were included in the study; the control group consisted of 49 people. The following tests were conducted for all study participants: carbohydrate metabolism evaluation, carotid artery duplex scan to measure intima-media complex thickness (IMT) and to determine the presence of atherosclerotic plaques, carotid-femoral pulse wave velocity (PWV) measurement and lymphocyte telomere length measurement. Results. The vascular changes were more pronounced in patients with T2DM than in controls. The telomeres were shorter in patients with T2DM than in those without diabetes (9.53 +/- 0.1 vs 9.86 +/- 0.1, p=0.033). The participants were divided according to the telomere length. Among patients with T2DM, there were significant differences in the condition of the vascular wall [PWV: 10.58 +/- 0.1 m/s in patients with 'long' telomeres and 15.08 +/- 1.3 m/s in patients with 'short' telomeres; IMT: 0.80 +/- 0.09 mm in patients with 'long' telomeres and 0.87 +/- 0.05 mm in patients with 'short' telomeres (p=0.024)]. There were no significant differences in the arterial structure between the patient and control groups with 'long' telomeres [PWV: 10.58 +/- 0.1 m/s vs 10.5 +/- 0.5 m/s (p=0.913); IMT: 0.080 +/- 0.09 mm vs 0.73 +/- 0.03 mm (p=0.12). However, there were significant differences in the vascular wall condition between the patient and control groups with 'short' telomeres [PWV: 15.08 +/- 1.3 m/s vs, 10.7 +/- 0.5 m/s (p=0.015); IMT: 0.87 +/- 0.1 vs 0.78 +/- 0.1 (p=0.03)]. Conclusions. The signs of vascular ageing were more pronounced in patients with T2DM than in controls. However, despite diabetes, vascular changes were minimal in patients with 'long' lymphocyte telomeres, comparable with the state of the vascular walls in healthy individuals. Thus, enhanced lymphocyte telomere length may have a protective effect on the vascular wall and may prevent damage from carbohydrate metabolism disorders.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [1] Protective effect of telomere length in patients with type 2 diabetes mellitus
    Dudinskaya, E. N.
    Brailova, N. V.
    Strazhesko, I. D.
    Tkacheva, O. N.
    Boytsov, S. A.
    Shestakova, M. V.
    [J]. DIABETOLOGIA, 2014, 57 : S505 - S505
  • [2] Telomere length, vascular aging and glycaemic variability in patients with type 2 diabetes
    Brailova, N. V.
    Dudinskaya, E.
    Strazhesko, I.
    Plochova, E.
    Akasheva, D.
    Tkacheva, O.
    Boytsov, S.
    Shestakova, M.
    [J]. DIABETOLOGIA, 2016, 59 : S517 - S517
  • [3] Correlation of the telomere length with type 2 diabetes mellitus in patients with ischemic heart disease
    Piplani, Shobhit
    Alemao, Nadezdha Niyarah
    Prabhu, Madhav
    Ambar, Sameer
    Chugh, Yashasvi
    Chugh, Sanjay Kumar
    [J]. INDIAN HEART JOURNAL, 2018, 70 : S173 - S176
  • [4] Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus
    Dudinskaya, E. N.
    Tkacheva, O. N.
    Shestakova, M. V.
    Brailova, N. V.
    Strazhesko, I. D.
    Akasheva, D. U.
    Isaykina, O. Y.
    Sharashkina, N. V.
    Kashtanova, D. A.
    Boytsov, S. A.
    [J]. ENDOCRINE CONNECTIONS, 2015, 4 (03): : 136 - 143
  • [5] Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus
    Testa, R.
    Olivieri, F.
    Sirolla, C.
    Spazzafumo, L.
    Rippo, M. R.
    Marra, M.
    Bonfigli, A. R.
    Ceriello, A.
    Antonicelli, R.
    Franceschi, C.
    Castellucci, C.
    Testa, I.
    Procopio, A. D.
    [J]. DIABETIC MEDICINE, 2011, 28 (11) : 1388 - 1394
  • [6] Association of leukocyte telomere length with metabolic syndrome in type 2 diabetes mellitus
    Peng, Xuemin
    Huang, Jiaojiao
    Xia, Sanshan
    Yang, Yan
    Dong, Kun
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2021, 26 (01):
  • [7] Vascular aging, telomere biology, oxidative stress and chronic inflammation in patients with type 2 diabetes mellitus
    Brailova, N.
    Dudinskaya, E.
    Strazhesko, I.
    Akasheva, D.
    Pokrovskaya, M.
    Tkacheva, O.
    Pykhtina, V.
    Boytsov, S.
    Shestakova, M.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 329 - 329
  • [8] Association between Telomere Length and Type 2 Diabetes Mellitus: A Meta-Analysis
    Zhao, Jinzhao
    Miao, Kun
    Wang, Haoran
    Ding, Hu
    Wang, Dao Wen
    [J]. PLOS ONE, 2013, 8 (11):
  • [9] Effects of Age and Biological Age-Determining Factors on Telomere Length in Type 2 Diabetes Mellitus Patients
    Tariq, Jawaria Ali
    Mandokhail, KaleemUllah
    Sajjad, Naheed
    Hussain, Abrar
    Javaid, Humera
    Rasool, Aamir
    Sadaf, Hummaira
    Javaid, Sadia
    Durrani, Abdul Rauf
    [J]. MEDICINA-LITHUANIA, 2024, 60 (05):
  • [10] Leukocyte telomere length and mortality risk in patients with type 2 diabetes
    Bonfigli, Anna Rita
    Spazzafumo, Liana
    Prattichizzo, Francesco
    Bonafe, Massimiliano
    Mensa, Emanuela
    Micolucci, Luigina
    Giuliani, Angelica
    Fabbietti, Paolo
    Testa, Roberto
    Boemi, Massimo
    Lattanzio, Fabrizia
    Olivieri, Fabiola
    [J]. ONCOTARGET, 2016, 7 (32) : 50835 - 50844